UK updates guidance for MoM hip patient follow-up with extended blood and MRI screening regime
This article was originally published in Clinica
Executive Summary
An estimated 49,000 UK patients with metal-on-metal (MoM) hip implants could face a life-time of annual check-ups after the country's Medicines and Healthcare products Regulatory Agency (MHRA) updated its April 2010 guidance on the follow-up protocol for these devices. The new guidance, which introduces a tighter blood testing and diagnostic imaging regime, is in response to growing concerns related to the risks posed by debris from wear and tear of these types of orthopaedic implants over time.